Leaflet SULFASALAZINA EN 500mg gastro-resistant tablets

Indicated for: inflammatory bowel disease

Route of administration: oral

Substance: sulfasalazine (immunomodulator)

ATC: A07EC01 (Alimentary tract and metabolism | Intestinal antiinflammatory agents | Aminosalicylic acid and similar agents)

Precautions:
Avoid live vaccines
Avoid live vaccines

Avoid live vaccines during treatment if contraindicated.

Immunosuppression / infection risk
Immunosuppression / infection risk

This medicine may increase the risk of infections.

Breastfeeding warning
Breastfeeding warning

Use during breastfeeding only on medical advice.

Pregnancy warning
Pregnancy warning

Use during pregnancy only on medical advice.

Sulfasalazine is a medication primarily used to treat inflammatory bowel diseases, such as ulcerative colitis and Crohn's disease, as well as rheumatoid arthritis. It is an anti-inflammatory and immunomodulatory agent that helps reduce inflammation and alleviate symptoms of these conditions.

In inflammatory bowel diseases, sulfasalazine is effective in inducing and maintaining remission, reducing symptoms like diarrhea, abdominal pain, and rectal bleeding. In rheumatoid arthritis, it is used to reduce joint pain, stiffness, and inflammation.

Common side effects include nausea, headaches, skin rashes, and gastrointestinal disturbances. In rare cases, it may cause severe allergic reactions, a decrease in blood cell counts, or liver function impairment.

Sulfasalazine should be used with caution in patients allergic to sulfonamides or salicylates. Regular monitoring of liver function and blood counts is important during treatment.

General data about SULFASALAZINA EN 500mg

  • Substance: sulfasalazine
  • Date of latest medicines list: 01-06-2026
  • Product code: W07440001
  • Concentration: 500mg
  • Pharmaceutical form: gastro-resistant tablets
  • Quantity: 50
  • Product type: Generic medicine
  • Price: 36.99 RON
  • Prescription status: P-6L - Medicines dispensed with a medical prescription that is not retained by the pharmacy and may be renewed; the prescription may be used for 6 months from the date of issue.

Marketing authorisation

  • Manufacturer: KRKA, D.D., NOVO MESTO - SLOVENIA
  • Holder: KRKA, D.D., NOVO MESTO - SLOVENIA
  • Number: 13702/2021/01
  • Shelf life: 5 years

Pharmaceutical forms available for sulfasalazine

Compensation lists for SULFASALAZINA EN 500mg KRKA

A - Sublist A with 90% discount from the reference price

Price

Copayment

Patient

36.99 RON

33.29 RON

3.70 RON

G18 (C1) - Rheumatoid arthritis, psoriatic arthropathy, severe chronic psoriasis and juvenile arthritis

Price

Copayment

Patient

36.99 RON

36.99 RON

0.00 RON

G19 (C1) - Ankylosing spondylitis

Price

Copayment

Patient

36.99 RON

36.99 RON

0.00 RON

GX (C1) - GENERIC (used in compensation list, C1, for another diagnosis)

Price

Copayment

Patient

36.99 RON

36.99 RON

0.00 RON